The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Leukemia and Lymphoma

• Publication date

  2011-05-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/10428194.2011.568649PMID 21438839PMCID PMC4136471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Obinutuzumab: the more the merrier?

  2016cited by this paper
• Hairy cell leukaemia: biological and clinical overview from immunogenetic insights

  2011influential reference
• Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.

  2010cited by this paper
• Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

  2010cited by this paper
• The Bruton's Tyrosine Kinase Inhibitor, PCI-32765, Is Well Tolerated and Demonstrates Promising Clinical Activity In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): An Update on Ongoing Phase 1 Studies

  2010cited by this paper
• The biology of hairy-cell leukaemia

  2010cited by this paper
• The microenvironment in mature B-cell malignancies: a target for new treatment strategies.

  2009cited by this paper
• Lymphoma microenvironment: culprit or innocent?

  2008cited by this paper
• Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia

  2008cited by this paper
• Stem cell trafficking in tissue development, growth, and disease.

  2008cited by this paper
• Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation

  2008cited by this paper
• Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?

  2008cited by this paper
• The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target

  2007cited by this paper
• Chronic lymphocytic leukemia: revelations from the B-cell receptor.

  2004cited by this paper
• TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.

  2004cited by this paper
• Chronic lymphocytic leukemia : revelations from the B-cell receptor

  2004influential reference
• TGF-β1 induces bone marrow reticulin fibrosis in hairy cell leukemia

  2004cited by this paper
• Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia

  2004cited by this paper
• Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas.

  2004cited by this paper
• Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

  2004cited by this paper
• Chemokine Receptor Expression in B-cell Lymphoproliferative Disorders

  2004cited by this paper
• Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins.

  2004cited by this paper
• The role of autocrine FGF-2 in the distinctive bone marrow fibrosis of hairy-cell leukemia (HCL).

  2003cited by this paper
• Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

  2003cited by this paper
• Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to Chemokines

  2002cited by this paper
• Differential expression of chemokine receptors in B cell malignancies

  2001cited by this paper
• Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones.

  1999cited by this paper
• Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

  1999cited by this paper
• Chemokines: signal lamps for trafficking of T and B cells for development and effector function

  1999cited by this paper
• T-cell dysfunction in hairy cell leukemia: an updated review.

  1998cited by this paper
• Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias

  1997cited by this paper
• Endothelial interactions of hairy cells: the importance of alpha 4 beta 1 in the unusual tissue distribution of the disorder.

  1996cited by this paper
• Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia.

  1996cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994cited by this paper
• Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen.

  1994cited by this paper
• Hairy cell interactions with extracellular matrix: expression of specific integrin receptors and their role in the cell's response to specific adhesive proteins.

  1994cited by this paper
• The bone marrow fibrosis of hairy-cell leukemia is caused by the synthesis and assembly of a fibronectin matrix by the hairy cells.

  1994cited by this paper
• Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes.

  1993cited by this paper
• Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

  1983cited by this paper
• Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukaemia.

  1983cited by this paper

• Immune activation and microenvironmental crosstalk in hairy cell leukemia.

  2026cites this paper
• The tumor microenvironment in hairy cell leukemia (HCL) and splenic B cell lymphoma with prominent nucleoli (SBLPN)

  2025cites this paper
• Hairy cell leukemia – etiopathogenesis, diagnosis and modern therapeutic approach

  2024influential citation
• Human RP105 monoclonal antibody enhances antigen-specific antibody production in unique culture conditions

  2024cites this paper
• In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia

  2021cites this paper
• Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues

  2021cites this paper
• Hairy Cell Leukaemia

  2020cites this paper
• Hairy cell leukemia: present and future directions

  2019cites this paper
• Update on hairy cell leukemia.

  2018cites this paper
• CD27-positive hairy cell leukemia-Japanese variant

  2016cites this paper
• The importance of the tissue microenvironment in hairy cell leukemia.

  2015cites this paper
• Opening the door for HIF1α tuning.

  2014cites this paper
• Hairy cell leukemia: Update on molecular profiling and therapeutic advances.

  2014cites this paper
• Update on the Biology and Treatment Options for Hairy Cell Leukemia

  2014cites this paper
• [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].

  2014cites this paper
• Motility and trafficking in B-cell non-Hodgkin's lymphoma (Review).

  2014cites this paper
• The bruton tyrosine kinase inhibitor ibrutinib (PCI‐32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach

  2014cites this paper
• Hairy cell: young living longer but not cured.

  2014cites this paper